BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 22322883)

  • 21. Disulfiram Chelated with Copper Promotes Apoptosis in Osteosarcoma via ROS/Mitochondria Pathway.
    Ren Y; Lin Y; Chen J; Jin Y
    Biol Pharm Bull; 2021; 44(10):1557-1564. PubMed ID: 34602566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antitumor effects of disulfiram/copper complex in the poorly-differentiated nasopharyngeal carcinoma cells via activating ClC-3 chloride channel.
    Xu X; Xu J; Zhao C; Hou X; Li M; Wang L; Chen L; Chen Y; Zhu L; Yang H
    Biomed Pharmacother; 2019 Dec; 120():109529. PubMed ID: 31606620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity.
    Chen D; Cui QC; Yang H; Dou QP
    Cancer Res; 2006 Nov; 66(21):10425-33. PubMed ID: 17079463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-cancer effects of disulfiram in head and neck squamous cell carcinoma via autophagic cell death.
    Park YM; Go YY; Shin SH; Cho JG; Woo JS; Song JJ
    PLoS One; 2018; 13(9):e0203069. PubMed ID: 30212479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disulfiram modulates ROS accumulation and overcomes synergistically cisplatin resistance in breast cancer cell lines.
    Yang Z; Guo F; Albers AE; Sehouli J; Kaufmann AM
    Biomed Pharmacother; 2019 May; 113():108727. PubMed ID: 30870721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disulfiram/Copper induces antitumor activity against gastric cancer via the ROS/MAPK and NPL4 pathways.
    Liu Y; Guan X; Wang M; Wang N; Chen Y; Li B; Xu Z; Fu F; Zheng Z; Du C
    Bioengineered; 2022 Mar; 13(3):6579-6589. PubMed ID: 35290151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective effect of N-acetyl-L-cysteine against disulfiram-induced oxidative stress and apoptosis in V79 cells.
    Grosicka-Maciąg E; Kurpios-Piec D; Grzela T; Czeczot H; Skrzycki M; Szumiło M; Rahden-Staroń I
    Toxicol Appl Pharmacol; 2010 Nov; 248(3):210-6. PubMed ID: 20708635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Green tea component, catechin, induces apoptosis of human malignant B cells via production of reactive oxygen species.
    Nakazato T; Ito K; Ikeda Y; Kizaki M
    Clin Cancer Res; 2005 Aug; 11(16):6040-9. PubMed ID: 16115949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The combination of disulfiram and copper for cancer treatment.
    Li H; Wang J; Wu C; Wang L; Chen ZS; Cui W
    Drug Discov Today; 2020 Jun; 25(6):1099-1108. PubMed ID: 32320854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential Cytotoxicity Mechanisms of Copper Complexed with Disulfiram in Oral Cancer Cells.
    Chen SY; Chang YL; Liu ST; Chen GS; Lee SP; Huang SM
    Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33918312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disulfiram facilitates intracellular Cu uptake and induces apoptosis in human melanoma cells.
    Cen D; Brayton D; Shahandeh B; Meyskens FL; Farmer PJ
    J Med Chem; 2004 Dec; 47(27):6914-20. PubMed ID: 15615540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytotoxic effect of disulfiram/copper on human cervical cancer cell lines and LGR5-positive cancer stem-like cells.
    Cao HZ; Yang WT; Zheng PS
    BMC Cancer; 2022 May; 22(1):521. PubMed ID: 35534815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antitumor activity of bortezomib alone and in combination with TRAIL in human acute myeloid leukemia.
    Conticello C; Adamo L; Vicari L; Giuffrida R; Iannolo G; Anastasi G; Caruso L; Moschetti G; Cupri A; Palumbo GA; Gulisano M; De Maria R; Giustolisi R; Di Raimondo F
    Acta Haematol; 2008; 120(1):19-30. PubMed ID: 18716397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. OSU-A9, an indole-3-carbinol derivative, induces cytotoxicity in acute myeloid leukemia through reactive oxygen species-mediated apoptosis.
    Bai LY; Weng JR; Chiu CF; Wu CY; Yeh SP; Sargeant AM; Lin PH; Liao YM
    Biochem Pharmacol; 2013 Nov; 86(10):1430-40. PubMed ID: 24041743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergistic Cytotoxicity of Melatonin and New-generation Anticancer Drugs Against Leukemia Lymphocytes But Not Normal Lymphocytes.
    Zhelev Z; Ivanova D; Bakalova R; Aoki I; Higashi T
    Anticancer Res; 2017 Jan; 37(1):149-159. PubMed ID: 28011485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resveratrol induces extensive apoptosis by depolarizing mitochondrial membranes and activating caspase-9 in acute lymphoblastic leukemia cells.
    Dörrie J; Gerauer H; Wachter Y; Zunino SJ
    Cancer Res; 2001 Jun; 61(12):4731-9. PubMed ID: 11406544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for the efficacy of disulfiram and copper combination in glioblastoma multiforme - A propos of a case.
    Karamanakos PN; Trafalis DT; Papachristou DJ; Panteli ES; Papavasilopoulou M; Karatzas A; Kardamakis D; Nasioulas G; Marselos M
    J BUON; 2017; 22(5):1227-1232. PubMed ID: 29135106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FDA-approved disulfiram as a novel treatment for aggressive leukemia.
    Karsa M; Xiao L; Ronca E; Bongers A; Spurling D; Karsa A; Cantilena S; Mariana A; Failes TW; Arndt GM; Cheung LC; Kotecha RS; Sutton R; Lock RB; Williams O; de Boer J; Haber M; Norris MD; Henderson MJ; Somers K
    J Mol Med (Berl); 2024 Apr; 102(4):507-519. PubMed ID: 38349407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel o-naphthoquinones induce apoptosis of EL-4 T lymphoma cells through the increase of reactive oxygen species.
    Di Rosso ME; Barreiro Arcos ML; Elingold I; Sterle H; Baptista Ferreira S; Ferreira VF; Galleano M; Cremaschi G; Dubin M
    Toxicol In Vitro; 2013 Oct; 27(7):2094-104. PubMed ID: 23933437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disulfiram: A novel repurposed drug for cancer therapy.
    Zeng M; Wu B; Wei W; Jiang Z; Li P; Quan Y; Hu X
    Chin Med J (Engl); 2024 Jun; 137(12):1389-1398. PubMed ID: 38275022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.